Watch This Space: Reliance Advances Protein-Based COVID-19 Vaccine
Huge Group's Digital Prowess An Advantage?
Executive Summary
Reliance Life Sciences, part of India’s largest private sector enterprise with a growing engagement in healthcare, is progressing an early-stage COVID-19 vaccine. A top executive underscores the potential to manufacture at scale and provide the protein-based candidate at a competitive price.